BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 28446515)

  • 1. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
    Chow SL; Maisel AS; Anand I; Bozkurt B; de Boer RA; Felker GM; Fonarow GC; Greenberg B; Januzzi JL; Kiernan MS; Liu PP; Wang TJ; Yancy CW; Zile MR;
    Circulation; 2017 May; 135(22):e1054-e1091. PubMed ID: 28446515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
    Konstam MA; Kiernan MS; Bernstein D; Bozkurt B; Jacob M; Kapur NK; Kociol RD; Lewis EF; Mehra MR; Pagani FD; Raval AN; Ward C;
    Circulation; 2018 May; 137(20):e578-e622. PubMed ID: 29650544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Wijdicks EF; Sheth KN; Carter BS; Greer DM; Kasner SE; Kimberly WT; Schwab S; Smith EE; Tamargo RJ; Wintermark M;
    Stroke; 2014 Apr; 45(4):1222-38. PubMed ID: 24481970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is New in Heart Failure Management in 2017? Update on ACC/AHA Heart Failure Guidelines.
    Bozkurt B
    Curr Cardiol Rep; 2018 Apr; 20(6):39. PubMed ID: 29667019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
    Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
    Goldstein LB; Bushnell CD; Adams RJ; Appel LJ; Braun LT; Chaturvedi S; Creager MA; Culebras A; Eckel RH; Hart RG; Hinchey JA; Howard VJ; Jauch EC; Levine SR; Meschia JF; Moore WS; Nixon JV; Pearson TA; ; ; ; ;
    Stroke; 2011 Feb; 42(2):517-84. PubMed ID: 21127304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic Peptides in Clinical Practice.
    Çavuşoğlu Y; Alper AT; Altay H; Çelik A; Demirkan B; Güvenç TS; Küçükoğlu MS; Nalbantgil S; Özdemir M; Özin B; Sayın T; Yıldırımtürk Ö; Yılmaz MB; Zorkun C
    Anatol J Cardiol; 2019 Mar; 21(Suppl 1):1-40. PubMed ID: 30860204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers: Their potential in the diagnosis and treatment of heart failure.
    Heil B; Tang WH
    Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S28-35. PubMed ID: 26694889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
    Ibrahim N; Januzzi JL
    Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble ST2 in heart failure.
    Dieplinger B; Mueller T
    Clin Chim Acta; 2015 Mar; 443():57-70. PubMed ID: 25269091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure.
    Motiwala SR; Januzzi JL
    Clin Pharmacol Ther; 2013 Jan; 93(1):57-67. PubMed ID: 23187878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel heart failure biomarkers: why do we fail to exploit their potential?
    Piek A; Du W; de Boer RA; Silljé HHW
    Crit Rev Clin Lab Sci; 2018 Jun; 55(4):246-263. PubMed ID: 29663841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group.
    Schocken DD; Benjamin EJ; Fonarow GC; Krumholz HM; Levy D; Mensah GA; Narula J; Shor ES; Young JB; Hong Y; ; ; ; ; ;
    Circulation; 2008 May; 117(19):2544-65. PubMed ID: 18391114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using biomarkers to guide heart failure management.
    Chang KW; Fox S; Mojaver S; Maisel AS
    Expert Rev Cardiovasc Ther; 2017 Oct; 15(10):729-741. PubMed ID: 28830266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort.
    Brouwers FP; van Gilst WH; Damman K; van den Berg MP; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van der Harst P; de Boer RA
    Circ Heart Fail; 2014 Sep; 7(5):723-31. PubMed ID: 25057112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association.
    Ferriero DM; Fullerton HJ; Bernard TJ; Billinghurst L; Daniels SR; DeBaun MR; deVeber G; Ichord RN; Jordan LC; Massicotte P; Meldau J; Roach ES; Smith ER;
    Stroke; 2019 Mar; 50(3):e51-e96. PubMed ID: 30686119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expert consensus on the usefulness of natriuretic peptides in heart failure.].
    Nessler J; Straburzyńska-Migaj E; Windak A; Solnica B; Szmitkowski M; Paradowski M; Kaźmierczak J; Puacz E; Rozentryt P
    Kardiol Pol; 2018; 76(1):215-224. PubMed ID: 29399772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].
    Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M
    G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Katzan IL; Spertus J; Bettger JP; Bravata DM; Reeves MJ; Smith EE; Bushnell C; Higashida RT; Hinchey JA; Holloway RG; Howard G; King RB; Krumholz HM; Lutz BJ; Yeh RW; ; ; ; ; ;
    Stroke; 2014 Mar; 45(3):918-44. PubMed ID: 24457296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.